Page 10 - Noninvasive Diagnostic Techniques for the Detection of Skin Cancers
P. 10

magnifying lens equipped with a polarized or nonpolarized light source (to deflect surface
               reflection) that is held near the suspicious lesion. Other diagnostic techniques include confocal
               microscopy, which produces images of skin lesions at various depths and is primarily used in
               research centers. Some of these devices have been approved or cleared by the FDA; others are in
               general use (e.g., photography). In addition, a number of imaging modalities are emerging to
               help improve the diagnostic accuracy of visual inspection of pigmented skin lesions. These
               include epidermal genetic tape stripping, ‘scent’/‘odor’ ultraviolet photography, fluorescence,
               ultrasound, laser Doppler, bio-electrical impedance, polarized light photography, 3-D histograms
               of color mapping, multispectral imaging and fully automated computer-based analysis, and
                             15
               thermography.  To evaluate these newer techniques, several comparators have been used. In
               addition to the direct comparison with the “gold standard,” the biopsy, several studies have
               highlight comparisons between the newer devices and the clinical exam, as well as head-to-head
               comparisons between these devices.

               Statement of Work/Objectives
                   The objectives of this technical brief are to provide a description of the state of the science of
               noninvasive imaging modalities in diagnosing cancerous tumors of the skin, proffer an analytic
               framework for assessing the applications of the devices, provide a summary of ongoing research,
               and to delineate future research needs.
                   Three principal forms of skin cancer will be considered: basal cell carcinoma (BCC) and
               squamous cell carcinoma (SCC), the more prevalent forms of skin cancer, and melanoma, among
               the most virulent. While the focus of this brief will be on modalities currently in general or
               limited clinical use and/or FDA approved or cleared, we also will consider investigational
               technologies based on available data and input from our key informants particularly the potential
               importance of these technologies and where they might fit into the care process.
                   For the purpose of the present discussion, we considered these modalities according to the
               degree of resolution of the skin lesions, ranging from clinical inspection (quaternary and tertiary)
               to delineation of cellular and subcellular structures (secondary and primary), adapted from
                               16
               Marghoob 2003.  We also examine whether there are indications of differing effectiveness
               among techniques for the early detection of skin cancers among Whites, Blacks, and Hispanics,
               and whether that should be a focus of future comparative effectiveness research. Whenever
               possible, we stratify the findings by whether or not the patients had a previous history of skin
               cancer and whether or not patients have a history of other malignancies. The rationale for this is
               the growing recognition of skin cancer as a leading form of second malignancy. 1,11  We also
               sought to assess the clinical application of these modalities and their diffusion across
               specialty/subspecialty groups.




















                                                              2
   5   6   7   8   9   10   11   12   13   14   15